Safety Study of MGA271 in Refractory Cancer

Clinical trial NCT01391143 · COMPLETED

Trial details

NCT number: NCT01391143
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Melanoma Renal Cell Carcinoma Triple-negative Breast Cancer Head and Neck Cancer Bladder Cancer Non-small Cell Lung Cancer

Start date: 2011-07-01
Primary completion: 2019-04-18
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.